Thomas Nyström

Thomas Nyström is a Professor/Senior Physician at Karolinska Institutet, part of the Department of Clinical Science and Education, Södersjukhuset. He co-leads the NeuroCardioMetabol Group, focusing on diabetes and obesity-related complications, particularly stroke. His research integrates preclinical models and clinical studies to identify therapies improving neurological recovery post-stroke. Key contributions include demonstrating the neuroprotective effects of GLP-1R agonists and DPP-4 inhibitors in diabetic stroke models.

Education: Not explicitly detailed in the text but inferred from his role as a professor.

Research Interests: Pathophysiological mechanisms of diabetes complications, stroke recovery, neuroprotection, and drug development. Uses experimental models to translate findings into clinical strategies.

Collaborations: Partnerships with institutions like Uppsala University, University of Gothenburg, and industry (e.g., Boehringer Ingelheim). Active in grants from Swedish Research Council, Heart-Lung Foundation, and others.

Grants & Awards: Multiple grants including Swedish Research Council (2022-2024), Swedish Heart-Lung Foundation (2020-2022), and Novo Nordisk Foundation (2018).

Publications: Over 100 articles, focusing on stroke recovery mechanisms, pharmacological interventions, and diabetic comorbidities. Recent highlights include SGLT2 inhibitor efficacy and weight-loss strategies in stroke recovery.